Trial of Bortezomib, Cytarabine, and Dexamethasone in Mantle Cell Lymphoma
Status:
Recruiting
Trial end date:
2025-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether bortezomib, cytarabine, and dexamethasone
are effective in the treatment of relapsed or refractory mantle cell lymphoma after 1 to 3
lines of previous treatment.